WHO ICTRP trial
Surgical versus medical castration therapy: Are the effects on risk factors for…
EUCTR2013-002553-29-DK · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2013-002553-29-DK |
|---|---|
| Public title | Surgical versus medical castration therapy: Are the effects on risk factors for cardiovascular disease and bone density different. |
| Scientific title | Metabolic changes due to iatrogenic hypogonadism in patients with prostate cancer: orchiectomy vs. triptorelin |
| Primary sponsor | Jens Sønksen |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Denmark |
| Conditions | Men with prostate cancer where lifelong castration is indicated MedDRA version: 16.0 Level: PT Classification code 10060862 Term: Prostate cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and… |
| Interventions | Trade Name: Pamorelin Pharmaceutical Form: Concentrate and solvent for solution for injection |
| Registration date | Jul 15, 2013 |
| Secondary IDs | kk-2013 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: